MedPath

Assessment of Hypoxia Before Radioembolization Treatment With 18F-FMISO PET

Completed
Conditions
Cancer
Radiotherapy
Positron Emission Tomography
Radioembolization
Interventions
Diagnostic Test: 18F-Fluoromisonidazole PET
Registration Number
NCT06027021
Lead Sponsor
Ankara University
Brief Summary

Hypoxia is a known factor for resistance to radiotherapy in tumors. Response to transarterial radioembolization is known to be variable between different patients even if the same dose of radiation was delivered. In this study the investigators aim to quantify the hypoxia in the primary and secondary tumors of liver with 18F-FMISO PET before radioembolization and to prove any effect of the hypoxia, if present, on the dose that should be delivered to tumor to ensure treatment response.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
64
Inclusion Criteria
  • Diagnosed with colorectal carcinoma with liver metastasis or hepatocellular carcinoma.
  • Is not eligible for surgery
  • Above 18 years old
  • The patients who are referred for transarterial radioembolization treatment to Ankara University School of Medicine Department of Nuclear Medicine.
Exclusion Criteria
  • Patients with ECOG performance score >1
  • Claustrophobia
  • Life expectancy shorter than 3 months
  • Pregnant or breast-feeding patients

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Treatment group18F-Fluoromisonidazole PETPatients received radioembolization with hepatocellular cancer or colorectal cancer liver metastases
Primary Outcome Measures
NameTimeMethod
Demonstrate the effect of the hypoxia in the success of the radioembolization treatment08/2024

Demonstrate the effect of the hypoxia in the success of the radioembolization treatment

The effect of the hypoxia on the dose-response relationships and required doses to achieve treatment response in the hypoxic and non-hypoxic group.08/2024

The effect of the hypoxia on the dose-response relationships and required doses to achieve treatment response in the hypoxic and non-hypoxic group.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ankara University

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath